Evidence map›Paper›PMID 27242443›Full record

ArticleFrontiers in cellular neuroscience2016

ATP Released by Injured Neurons Activates Schwann Cells.

Samuele Negro, Elisanna Bergamin, Umberto Rodella, Elisa Duregotti, Michele Scorzeto, Kees Jalink, Cesare Montecucco, Michela Rigoni

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Mechanism of ERK/CREB pathway in pain and analgesia.Frontiers in molecular neuroscience · 2023
    Review
  6. Article
  7. Review
  8. MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Metabolic Transporters in the Peripheral Nerve-What, Where, and Why?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Moving forward with the neuromuscular junction.Journal of neurochemistry · 2017
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Samuele NegroDepartment of Biomedical Sciences, University of Padova Padua, Italy.
Elisanna BergaminDepartment of Biomedical Sciences, University of Padova Padua, Italy.
Umberto RodellaDepartment of Biomedical Sciences, University of Padova Padua, Italy.
Elisa DuregottiDepartment of Biomedical Sciences, University of Padova Padua, Italy.
Michele ScorzetoDepartment of Biomedical Sciences, University of Padova Padua, Italy.
Kees JalinkDivision of Cell Biology, The Netherlands Cancer Institute Amsterdam, Netherlands.
Cesare MontecuccoDepartment of Biomedical Sciences, University of PadovaPadua, Italy; National Research Council, Institute of NeurosciencePadua, Italy.
Michela RigoniDepartment of Biomedical Sciences, University of Padova Padua, Italy.
University of Padua · ITThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Injured nerve terminals of neuromuscular junctions (NMJs) can regenerate. This remarkable and complex response is governed by molecular signals that are exchanged among the cellular components of this synapse: motor axon nerve terminal (MAT), perisynaptic Schwann cells (PSCs), and muscle fiber. The nature of signals that govern MAT regeneration is ill-known. In the present study the spider toxin α-latrotoxin has been used as tool to investigate the mechanisms underlying peripheral neuroregeneration. Indeed this neurotoxin induces an acute, specific, localized and fully reversible damage of the presynaptic nerve terminal, and its action mimics the cascade of events that leads to nerve terminal degeneration in injured patients and in many neurodegenerative conditions. Here we provide evidence of an early release by degenerating neurons of adenosine triphosphate as alarm messenger, that contributes to the activation of a series of intracellular pathways within Schwann cells that are crucial for nerve regeneration: Ca(2+), cAMP, ERK1/2, and CREB. These results contribute to define the cross-talk taking place among degenerating nerve terminals and PSCs, involved in the functional recovery of the NMJ.

Indexed as

apyraseATPcalciumcAMPCREBERK 1/2primary neuronsSchwann cells

Identifiers

PMID27242443
PMCPMC4876115
OpenAlexW2394815890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.